- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02756377
A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases
A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases (A Randomized, Double-blind Clinical Trials)
Aim: clinical effectiveness of 0.05% cetylpyridinium chloride mouth rinse in patients with gingivitis as compared to non-alcoholic chlorhexidine mouth wash.
Methods & Material: Twenty-four subjects, without systemic diseases, with plaque-induced gingivitis will be selected for this study. The patients were treated with scaling and root planing at the baseline; Oral hygiene instructions were given that included brushing twice- daily, The volunteers brushed their teeth with the Bass brushing technique for at least 2 minutes, these patients were randomly ,equally divided into two groups, Group A: perform daily mouthwashes twice a day with the solution containing 10 ml of 0.05 cetyl pyridinium, (Vi-one, Rojin, Cosmetic-Lab, Kurdistan -Iran), Group B: use daily mouthwashes twice a day with 10ml of the chlorhexidine(Kin Laboratories, Spain), On day 0,7,15 and day 21 of each phase the Plaque Index (PI), Pocket depth(PD), Stain Index(SI) and Bleeding Index (BI) of each volunteer were measured.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:Inclusion criteria: adult patients with gingivitis, older than 18 years old, systemically healthy, and having at least 20 teeth.
Exclusion Criteria:patients with cavitated caries, no periodontal pockets larger than 4 mm, orthodontic appliances or removable prostheses, allergies to cetyl pyridinium or CHX, use of antibiotics and anti-inflammatory drugs in the past 3 months that might alter normal gingival health, oral prophylaxis outside of study; use of oral chlorhexidine products or participation in an oral rinse study within 3 months prior to baseline examination, pregnancy or nursing, smoking.
Study Population 34 eligibles were enrolled in the study, was designed as a Randomized, Double-blind clinical trials.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: cetylpyridinium chloride
mouthwash (cetylpyridinium chloride)10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
|
cetylpyridinium chloride mouthwash, 10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
Other Names:
Chlorhexidine mouthwash,10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
Other Names:
|
Active Comparator: Chlorhexidine mouthwash
mouthwash ( Alcohol-free chlorhexidine)10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
|
cetylpyridinium chloride mouthwash, 10 ml by patients routinely washed two times in one day for about 30 seconds for two weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of bleeding on probing
Time Frame: 7 days
|
Periodontal pobe
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of plaque index
Time Frame: 7 days
|
Plaque Index (O'Leary)
|
7 days
|
Reduction of pocket depth
Time Frame: 7days
|
Periodontal pobe
|
7days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 483
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontal Diseases
-
G. d'Annunzio UniversityNot yet recruitingPeriodontal Diseases | Intrabony Periodontal Defect | Periodontal Attachment Loss | Pocket, Periodontal
-
University of BeykentCompletedPeriodontal Diseases | Periodontal Attachment Loss | Periodontal Inflammation | Periodontal Disease, AVDC Stage 3 | Periodontal Disease, AVDC Stage 4Turkey
-
British University In EgyptRecruitingPeriodontal Diseases | Periodontal Pocket | Periodontal Attachment Loss | Periodontal InflammationEgypt
-
Technische Universität DresdenCompletedPeriodontal Disease | Periodontal Attachment LossGermany
-
Universidad de MurciaCompletedPeriodontitis | Periodontal Diseases | Periodontal Pocket | Periodontal Attachment LossSpain
-
Brock UniversityDr. Peter C. Fritz, Periodontal Wellness & Implant SurgeryCompletedPeriodontal Pocket | Periodontal Attachment LossCanada
-
Texas A&M UniversityInstitut Straumann AGRecruitingPeriodontitis | Attachment Loss, PeriodontalUnited States
-
Queen Mary University of LondonGeistlich Pharma AGNot yet recruitingPeriodontal Diseases | Wound Heal | Periodontal Pocket | Periodontal Attachment Loss | Periodontal InflammationUnited Kingdom
-
University of FlorenceRecruitingPeriodontitis | Periodontal Pocket | Periodontal Attachment LossItaly
-
Brock UniversityDr. Peter C. Fritz, Periodontal Wellness & Implant SurgeryCompleted
Clinical Trials on cetylpyridinium chloride mouthwash
-
Colgate PalmoliveCompletedGingivitis | Dental PlaquePuerto Rico
-
Tufts UniversityCompletedReduction in Bacterial Counts Through the Use of MouthwashUnited States
-
Dentaid SLFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaboratorsCompleted
-
Peking University People's HospitalCompletedGingivitis | Pharyngitis AcuteChina
-
University of California, San FranciscoRowpar Pharmaceuticals, Inc.TerminatedCoronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus DiseaseUnited States
-
Rosa TarragoDentaid SLCompletedCOVID-19 | SARS-CoV-2 InfectionSpain
-
Colgate PalmoliveCompletedGingivitis | Dental PlaqueUnited States
-
University of Illinois at ChicagoCompletedWound Heal | Oral MicrobiomeUnited States
-
University of Toledo Health Science CampusProMedica Health System; The University of Toledo; ARMS Pharmaceutical LLC; Pediatric...WithdrawnViral Upper Respiratory Tract InfectionUnited States
-
Aziende Chimiche Riunite Angelini Francesco S.p.ACross Research S.A.Completed